Chemoenzymatic Labeling Pathogens Containing Terminal N-Acetylneuraminic Acid−α(2–3)-Galactose Glycans

Qizheng Wu,Jinfeng Ye,Yicong Chao,Shuchen Dong,Min Niu,Yaqian Wang,Zhaoxi Liu,Wang Chen,Ningning Ge,Shuhua Lu,Peng George Wang,Min Chen
DOI: https://doi.org/10.1021/acsinfecdis.2c00011
IF: 5.578
2022-02-18
ACS Infectious Diseases
Abstract:The N-acetylneuraminic acid-α(2-3)-galactose epitope is often located at the nonreducing terminal ends of glycans on the envelopes of many pathogens, and it is believed that this structure mimics a host's oligosaccharide so as to circumvent and/or counteract the host's immune responses. A chemoenzymatic method for the rapid and sensitive detection of N-acetylneuraminic acid-α(2-3)-galactose has been built, so we planned to examine whether the chemoenzymatic method could be applied on the detection of N-acetylneuraminic acid-α(2-3)-galactose on pathogens. Our results revealed that the chemoenzymatic method was rapid and sensitive for labeling live or dead Gram-positive <i>Streptococcus agalactiae</i> A909 and Gram-negative <i>Campylobacter jejuni</i> MK104 with N-acetylneuraminic acid-α(2-3)-galactose. This study suggested that the chemoenzymatic method was a new strategy for labeling pathogens and had potential for the diagnosis of or therapeutics for pathogenic infection.
chemistry, medicinal,infectious diseases
What problem does this paper attempt to address?